Machine Learning AI Therapeutics Announces Name Change to OrphAI Therapeutics PRNewswire Oct 1, 2023 AI Therapeutics, a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced that it has changed its name to…
Life Sciences Deep Genomics Appoints Jeffrey M. Brown, Ph.D., Vice President of Preclinical Research AIT News Desk May 3, 2021 Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced the appointment of Jeffrey Brown, Ph.D., Vice President,…